Publication & White Papers
Feed
Category:Allpublicationsnewsinsights
No items available
In the Spotlight
![](/static/645b0ae01a68b68e94856f942d7687e9/1fcc6/Blue-Minimalist-Quotes-LinkedIn-Post-e1719471703559.webp)
Exploring the Complement System: A Double-Edged Sword in Drug Development.
![](/static/7d2b66271c4d7fe5565a2467fd70c94b/5f959/dna-4.webp)
Antisense Oligonucleotides - enhance your preclinical development with insights from ASO-expert
![](/static/4f8072adf7942628344b58c0187669a8/94819/Newsletter.webp)
Khaled and Ali's extensive research backgrounds are an invaluable resource internally and for our many customers.
![](/static/189f4324251324fdc61e10ab7798b33e/d603c/2022-02-25-Immuneed-4.webp)
Human whole blood analysis as an invaluable tool for understanding potential toxicity including human-specific immune reactions that can be hard to predict.
![](/static/f688a9e07cc36698892b0e54ae78386b/d603c/AdobeStock_248516675-scaled.webp)
Attempting to harness the body’s adaptive defense system into a drug? In this post, discover different factors to consider when trying to strike the right balance between the safety and efficacy of your antibody.
![](/static/64e8d823de557d07a18666e8344823b7/ad03e/Erika-Fletcher-blog.webp)
An interview with Scientific Advisor Erika Fletcher. To the clients she works with, Erika Fletcher’s sharp scientific mind is one of Immuneed’s strongest assets.
![](/static/116992593d2bbf74cc30b3423905b9b0/4dac1/AdobeStock_229048366-scaled.webp)
New paper featuring Immuneed. Donor-specific immune effector signatures of CLL patients in response to anti-CD20.
![](/static/104e0924ac3d0416ad7910a3679ddefb/e3d04/Bild-pa-Sara2-scaled-e1622126745416.webp)
The spark behind Immuneed. An interview with founder Sara Mangsbo.
![](/static/d179ba7061c66e5e5b77434481e9dd66/a29e4/wing-intro.webp)
Director of Business Science
![](/static/e6f8740a3c86d08909a801cfe2e7439c/5f959/Frame-7-2.webp)
Animal Testing – from Mandatory to Optional to Last Resort